Global Generic Injectables Market Insights and Forecast to 2026

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc.

Market Analysis and Insights: Global Generic Injectables Market
The global Generic Injectables market size is projected to reach US$ 26870 million by 2026, from US$ 25420 million in 2020, at a CAGR of 5.3%% during 2021-2026.

Global Generic Injectables Scope and Market Size
Generic Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Generic Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Generic Injectables market is segmented into
Large Molecule Injectables (Biosimilars)
Small Molecule Injectables

Segment by Application, the Generic Injectables market is segmented into
Oncology
Infectious Diseases
Cardiology
Diabetes
Immunology

Regional and Country-level Analysis
The Generic Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Generic Injectables market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape

and Generic Injectables Market Share Analysis
Generic Injectables market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Generic Injectables business, the date to enter into the Generic Injectables market, Generic Injectables product introduction, recent developments, etc.

The major vendors covered:
Pfizer
Sandoz International
Baxter
Fresenius
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
Lupin Pharmaceuticals
Sanofi
Biocon

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports